National / Science & Health Dec 25, 2022
Japan medical bodies aim to develop tailored drugs to treat rare diseases
Japanese researchers plan to develop tailored drugs and treatments for patients with extremely rare diseases.
Japan medical bodies aim to develop tailored drugs to treat rare diseases
Japanese researchers plan to develop tailored drugs and treatments for patients with extremely rare diseases.
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon. Sysmex’s diagnostic product that measures amyloid beta in the ...
Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
Johnson & Johnson's Japan unit searched over alleged antitrust violation
The Japan Fair Trade Commission suspects Johnson & Johnson K.K. and ASP Japan of obstructing competitors' sales of cleaners and disinfectants for endoscopes.
Shionogi says Japan government to buy 1 million more COVID pill doses
The added supply agreement comes at a time when Japan is dealing with an eighth wave of COVID-19 infections.
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Researchers test mRNA technology for universal flu vaccine
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
Shionogi applies for COVID-19 vaccine approval, would be first Japan-made
The recombinant protein-based preventive vaccine is the same type as a COVID-19 vaccine developed by Novavax and differs from messenger RNA vaccines developed by Pfizer or Moderna.
Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial
Approval would give Japan a home-grown source for mRNA vaccines, which have made up the bulk of its COVID-19 inoculations to date.
Lotte made its name in candy. Now it’s moving into drugmaking.
The new direction comes after a number of prominent South Korean family-run businesses turned to the highly profitable $1.3 trillion global biopharma business.